InvestorsHub Logo
Followers 19
Posts 628
Boards Moderated 0
Alias Born 04/17/2013

Re: relocatedmetsfan post# 220875

Thursday, 10/24/2019 1:33:39 PM

Thursday, October 24, 2019 1:33:39 PM

Post# of 425648
Reloc:

Yes, I was talking about the ADCOM for approval of EXONDYS51 IN 2011...the new indication for GOLODISSEN in the ESSENCE STUDY has the same problems with amount of patients included and the results reached... why you mentioned it to begin with is questionable....

You started posting in Dec,2018, which would indicate that you are an options player..... please identify as such...

Review the amount of shares traded (1-2 days ) after JT, gave a sales update for yr 2019 a few months ago...this catalyst ( ADCOM ) is so much more.....

You are soft bashing !!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News